Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Samsung Biologics | Seoul | Healthcare | Pharmaceuticals | ₩71.1T | 56.5x | 1.3 | ₩996,000 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.1% Upside | Upgrade to Pro+ | |
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩35.49T | 70.9x | 62.16 | ₩160,000 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38% Upside | Upgrade to Pro+ | |
Alteogen | KOSDAQ | Healthcare | Pharmaceuticals | ₩20.57T | 167.3x | 0.45 | ₩388,500 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.8% Upside | Upgrade to Pro+ | |
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩7.59T | 124.6x | -2.4 | ₩101,800 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.1% Upside | Upgrade to Pro+ | |
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩7.59T | 124.6x | -2.4 | ₩97,600 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sk Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩7.2T | 29x | 0.02 | ₩91,500 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩6.28T | -34.9x | 1.06 | ₩47,450 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharma Reaserch Products | KOSDAQ | Healthcare | Pharmaceuticals | ₩5.19T | 42.9x | 1.03 | ₩496,000 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.9% Downside | Upgrade to Pro+ | |
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩4.74T | -187.2x | 7.89 | ₩205,500 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Classys Inc | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩4.1T | 39x | 1.75 | ₩62,500 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.4% Upside | Upgrade to Pro+ | |
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩4.02T | 159.9x | 1.12 | ₩112,800 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.4% Upside | Upgrade to Pro+ | |
SK Bioscience Co | Seoul | Healthcare | Pharmaceuticals | ₩3.84T | -73.9x | 0.27 | ₩48,800 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -27.6% Downside | Upgrade to Pro+ | |
Hugel | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.84T | 28.7x | 0.51 | ₩371,500 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.6% Upside | Upgrade to Pro+ | |
Hanmi Pharm Co | Seoul | Healthcare | Pharmaceuticals | ₩3.68T | 35.2x | -1.11 | ₩293,000 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.9% Upside | Upgrade to Pro+ | |
Sam Chun Dang Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.53T | -320.8x | 17.69 | ₩152,900 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.34T | 1.02 | ₩40,650 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.2T | -47.1x | 0.54 | ₩66,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.2% Upside | Upgrade to Pro+ | |
Hanmi Science | Seoul | Healthcare | Pharmaceuticals | ₩3.01T | 55.5x | -1.05 | ₩44,900 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Celltrion Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩2.17T | 84x | ₩49,800 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.97T | -41.9x | 16.76 | ₩113,300 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nature Cell | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.89T | -9,589.7x | ₩29,550 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Daewoong Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.67T | 47.3x | -0.66 | ₩143,900 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45.4% Upside | Upgrade to Pro+ | |
Caregen | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.61T | 50x | -4.48 | ₩32,150 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.3% Upside | Upgrade to Pro+ | |
ST Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.6T | 54.3x | 2 | ₩78,000 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.1% Upside | Upgrade to Pro+ | |
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.57T | 147.1x | 0.37 | ₩33,900 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.3% Upside | Upgrade to Pro+ | |
Lunit | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩1.54T | -16.7x | 0.26 | ₩51,200 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.2% Downside | Upgrade to Pro+ | |
GC Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.47T | 51.4x | 0.26 | ₩127,700 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GI Innovation | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.35T | ₩21,450 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Hanall Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.28T | -763.8x | 5.46 | ₩24,850 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SD Biosensor | Seoul | Healthcare | Healthcare Equipment & Supplies | ₩1.28T | -13.2x | -0.2 | ₩10,740 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -15.9% Downside | Upgrade to Pro+ | |
HK Inno.N | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.2T | 30.1x | ₩42,400 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Medy-Tox | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.16T | 64x | 0.07 | ₩165,400 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.1% Upside | Upgrade to Pro+ | |
Mezzion Pharma | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.15T | -52.1x | 0.44 | ₩38,650 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chong Kun Dang Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.1T | 11.4x | -0.23 | ₩82,800 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.9% Upside | Upgrade to Pro+ | |
Oscotec | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.08T | 2,739.3x | 27.97 | ₩28,900 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Won Tech Co | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩976.12B | 27.5x | 4.95 | ₩10,850 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.2% Downside | Upgrade to Pro+ | |
Daewoong | Seoul | Healthcare | Pharmaceuticals | ₩930.26B | 15.7x | -0.28 | ₩22,250 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
Pharmicell | Seoul | Healthcare | Pharmaceuticals | ₩837.06B | -18.8x | ₩13,630 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Dongkook Pharmaceutical | KOSDAQ | Healthcare | Pharmaceuticals | ₩774.64B | 13.1x | 0.95 | ₩17,130 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.3% Upside | Upgrade to Pro+ | |
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩748.41B | -15.7x | 0.16 | ₩37,100 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Cross | Seoul | Healthcare | Pharmaceuticals | ₩738.1B | 11.1x | 0.06 | ₩16,160 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Cross Holdings | Seoul | Healthcare | Pharmaceuticals | ₩738.1B | 11.1x | 0.06 | ₩42,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Donga Socio Holdings | Seoul | Healthcare | Pharmaceuticals | ₩722.73B | 11.6x | 0.49 | ₩110,500 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.2% Upside | Upgrade to Pro+ | |
Viol | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩714.28B | 44.5x | ₩12,390 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Shinpoong Pharmaceutical Co | Seoul | Healthcare | Pharmaceuticals | ₩714.19B | -67.8x | -0.75 | ₩37,350 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shinpoong Phar | Seoul | Healthcare | Pharmaceuticals | ₩714.19B | -67.8x | -0.75 | ₩13,260 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Boryung Pharm | Seoul | Healthcare | Pharmaceuticals | ₩696.89B | 13.1x | -0.77 | ₩8,290 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chabiotech | KOSDAQ | Healthcare | Healthcare Providers & Services | ₩671.12B | -40.4x | -0.97 | ₩11,370 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
L&C Bio | KOSDAQ | Healthcare | Healthcare Equipment & Supplies | ₩659.79B | 5.3x | 0.03 | ₩26,550 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curiox BioSystems | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩628.73B | -44x | 6.41 | ₩38,850 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |